Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care. It
is applicable to specialists, primary care practitioners, and providers at all levels. is Guideline should
not be considered exclusive of other methods of care reasonably directed at obtaining the same results.
e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician
aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated with
the distributor of this clinical reference tool.
Abbreviations
ABI, ankle-brachial index; ACC, American College of Cardiolog y; AHA, American Heart
Association; ApoB, apolipoprotein B; ASCVD, atherosclerotic cardiovascular disease; CAC,
coronary artery calcium; CIMT, carotid intima-media thickness; CKD, chronic kidney disease;
COR, class of recommendation; CV, cardiovascular; CVD, cardiovascular disease; ES, evidence
statement; HDL-C, high-density lipoprotein cholesterol; HF, heart failure; hs-CRP, high-
sensitivity C-reactive protein; LOE, Level of Evidence; MI, myocardial infarction; NHLBI,
National Heart, Lung, and Blood Institute ; SBP, systolic blood pressure
Source
Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P,
Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie
P, Stone NJ, Wilson PWF. 2013 ACC/AHA guideline on the assessment of cardiovascular risk:
a report of the American College of Cardiolog y/American Heart Association Task Force on
Practice Guidelines. Published online before print November 12, 2013, J Am Coll Cardiol: doi:
10.1016/j.jacc.2013.11.005. and Circulation: 10.1161/01.cir.0000437741.48606.98.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies: info@GuidelineCentral.com
Copyright © 2014 All rights reserved
ACCCVR14033c
